123 related articles for article (PubMed ID: 9475626)
1. Dissociation of hippocampal serotonin release and locomotor activity following pharmacological manipulations of the median raphe nucleus.
Shim I; Javaid J; Wirtshafter D
Behav Brain Res; 1997 Dec; 89(1-2):191-8. PubMed ID: 9475626
[TBL] [Abstract][Full Text] [Related]
2. GABA(B) receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity.
Varga V; Sik A; Freund TF; Kocsis B
Neuroscience; 2002; 109(1):119-32. PubMed ID: 11784704
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.
Hutson PH; Sarna GS; O'Connell MT; Curzon G
Neurosci Lett; 1989 May; 100(1-3):276-80. PubMed ID: 2474776
[TBL] [Abstract][Full Text] [Related]
4. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
[TBL] [Abstract][Full Text] [Related]
5. Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus.
Wirtshafter D; Klitenick MA; Asin KE
Pharmacol Biochem Behav; 1987 May; 27(1):45-52. PubMed ID: 2441421
[TBL] [Abstract][Full Text] [Related]
6. Dissociable roles for the dorsal and median raphé in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization.
Szumlinski KK; Frys KA; Kalivas PW
Neuropsychopharmacology; 2004 Sep; 29(9):1675-87. PubMed ID: 15127081
[TBL] [Abstract][Full Text] [Related]
7. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity.
Sharp T; Bramwell SR; Clark D; Grahame-Smith DG
J Neurochem; 1989 Jul; 53(1):234-40. PubMed ID: 2470860
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
Matos FF; Korpinen C; Yocca FD
Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
[TBL] [Abstract][Full Text] [Related]
9. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.
Matos FF; Urban C; Yocca FD
J Neural Transm (Vienna); 1996; 103(1-2):173-90. PubMed ID: 9026372
[TBL] [Abstract][Full Text] [Related]
10. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
[TBL] [Abstract][Full Text] [Related]
11. In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin.
Adell A; Carceller A; Artigas F
J Neurochem; 1993 May; 60(5):1673-81. PubMed ID: 7682600
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats.
Tao R; Ma Z; Auerbach SB
Br J Pharmacol; 1996 Dec; 119(7):1375-84. PubMed ID: 8968546
[TBL] [Abstract][Full Text] [Related]
13. Effects of 8-OHDPAT administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats.
Romaniuk A; Koprowska M; Krotewicz M; Strzelczuk M; Wieczorek M
Behav Brain Res; 2001 Apr; 120(1):47-57. PubMed ID: 11173084
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of NMDA on extracellular serotonin in rat midbrain raphe and forebrain sites.
Tao R; Auerbach SB
J Neurochem; 1996 Mar; 66(3):1067-75. PubMed ID: 8769868
[TBL] [Abstract][Full Text] [Related]
15. Muscimol injections into the median raphe nucleus increase serum ACTH and corticosterone concentrations via a nonserotonergic mechanism.
Paris JM; Lorens SA; Lee JM; Mitsushio H; Ritchie JC; Nemeroff CB
Pharmacol Biochem Behav; 1991 Jul; 39(3):765-8. PubMed ID: 1723800
[TBL] [Abstract][Full Text] [Related]
16. Intra-raphe muscimol induced hyperactivity depends on ascending serotonin projections.
Sainati SM; Lorens SA
Pharmacol Biochem Behav; 1982 Nov; 17(5):973-86. PubMed ID: 6294690
[TBL] [Abstract][Full Text] [Related]
17. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin.
Bosker F; Klompmakers A; Westenberg H
J Neurochem; 1994 Dec; 63(6):2165-71. PubMed ID: 7964736
[TBL] [Abstract][Full Text] [Related]
18. Is dopamine involved in the hyperactivity produced by injections of muscimol into the median raphe nucleus?
Wirtshafter D; Klitenick MA; Asin KE
Pharmacol Biochem Behav; 1988 Jul; 30(3):577-83. PubMed ID: 3211966
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety.
Dos Santos L; de Andrade TG; Zangrossi H
Psychopharmacology (Berl); 2005 Jun; 179(4):733-41. PubMed ID: 15619105
[TBL] [Abstract][Full Text] [Related]
20. Median and dorsal raphe injections of the 5-HT1A agonist, 8-OH-DPAT, and the GABAA agonist, muscimol, increase voluntary ethanol intake in Wistar rats.
Tomkins DM; Sellers EM; Fletcher PJ
Neuropharmacology; 1994; 33(3-4):349-58. PubMed ID: 7984273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
